Danaher Corporation $DHR Shares Sold by Roundview Capital LLC

Roundview Capital LLC reduced its position in shares of Danaher Corporation (NYSE:DHR) by 54.1% during the 2nd quarter, Holdings Channel.com reports. The firm owned 15,476 shares of the conglomerate’s stock after selling 18,224 shares during the quarter. Roundview Capital LLC’s holdings in Danaher were worth $3,057,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. KLP Kapitalforvaltning AS raised its position in shares of Danaher by 2.6% in the second quarter. KLP Kapitalforvaltning AS now owns 234,751 shares of the conglomerate’s stock valued at $46,437,000 after buying an additional 6,000 shares during the last quarter. Hardy Reed LLC raised its holdings in Danaher by 8.2% in the 2nd quarter. Hardy Reed LLC now owns 8,184 shares of the conglomerate’s stock valued at $1,617,000 after acquiring an additional 621 shares during the last quarter. Spear Holdings RSC Ltd lifted its stake in shares of Danaher by 50.6% during the 2nd quarter. Spear Holdings RSC Ltd now owns 409,384 shares of the conglomerate’s stock worth $80,870,000 after purchasing an additional 137,484 shares during the period. Capital Advisors Inc. OK boosted its holdings in shares of Danaher by 1.7% during the second quarter. Capital Advisors Inc. OK now owns 174,322 shares of the conglomerate’s stock worth $34,435,000 after purchasing an additional 2,996 shares during the last quarter. Finally, Red Tortoise LLC grew its position in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DHR has been the topic of a number of research analyst reports. UBS Group decreased their price target on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Barclays restated an “overweight” rating and issued a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Bank of America cut their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research note on Saturday, September 27th. Seventeen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $245.91.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by insiders.

Danaher Price Performance

DHR opened at $211.65 on Tuesday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a 50 day moving average of $200.36 and a two-hundred day moving average of $197.24. The company has a market cap of $151.55 billion, a P/E ratio of 45.03, a P/E/G ratio of 3.06 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the firm posted $1.72 EPS. The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is presently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.